Comparative in vitro study on binary Mg-RE (Sc, Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb and Lu) alloy systems
Source abstract
Abstract
Correct selection of alloying elements is important for developing novel biodegradable magnesium alloys with superior mechanical and biological performances. In contrast to various reports on nutrient elements (Ca, Zn, Sr, etc.) as alloying elements of biomedical magnesium alloys, there is limited information about how to choose the right rare earth elements (REEs) as alloying elements of magnesium. In this work, 16 kinds of REEs were individually added into Mg, including Sc, Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Du, Ho, Er, Tm, Yb and Lu, to fabricate binary Mg-RE model alloys with different composition points. Under the same working history, comparative studies were undertaken and the impact of each kind of rare earth element on the microstructure, mechanical property, corrosion behavior and biocompatibility of Mg were investigated. The corresponding influence level for the 16 kinds of REEs were ranked. The results showed that the second phases were detected in some Mg-RE alloys, which were mainly composed of Mg12RE. By adding different REEs into Mg with proper contents, the mechanical properties of resulting Mg-RE binary alloys could be adjusted in wide range. The corrosion resistance of Mg-light REE alloys was generally better than Mg-heavy REE alloys. As for biocompatibility, Mg-RE model alloys showed no cytotoxic effect on MC3T3-E1 cells. The hemolysis rates of all experimental Mg-RE model alloys were lower than 5% except for Mg-Lu alloy model. In general, the addition of different REEs into Mg could improve its performance from different aspects. This work provides a better understanding on suitable REEs as alloying elements for magnesium, and the future R&D direction on biomedical Mg-RE alloys was proposed. STATEMENT OF SIGNIFICANCE: In contrast to various reports on nutrient elements (Ca, Zn, Sr, etc.) as alloying elements of biomedical magnesium alloys, until now there is limited information about how to choose the right rare earth elements (REEs) as alloying elements of magnesium. In this work, comparative studies were undertaken by individually adding 16 kinds of REEs, including Sc, Y, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Du, Ho, Er, Tm, Yb and Lu, into Mg to fabricate binary Mg-RE model alloys, with different composition points, then the impact of each kind of rare earth element on the microstructure, mechanical property, corrosion behavior and biocompatibility of Mg under the same working history were investigated, and the corresponding influence level for the 16 kinds of REEs were ranked. This work provides a better understanding on suitable REEs as alloying elements for magnesium, and the future R&D direction on biomedical Mg-RE alloys was proposed.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Hydrogen Storage and Materials · Magnetic Properties of Alloys
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (97)
Show source-provided references
1. Novel magnesium alloys developed for biomedical application: a review10.1016/j.jmst.2013.02.005 ↗
2. Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats10.1038/nm.4162 ↗
3. Biodegradable metals10.1016/j.mser.2014.01.001 ↗
4. In vitro studies of biomedical magnesium alloys in a simulated physiological environment: a review10.1016/j.actbio.2010.12.004 ↗
5. Recent advances on the development of magnesium alloys for biodegradable implants10.1016/j.actbio.2014.07.005 ↗
6. In vitro corrosion and biocompatibility of binary magnesium alloys10.1016/j.biomaterials.2008.10.021 ↗
7. In vitro and in vivo studies on a mg–sr binary alloy system developed as a new kind of biodegradable metal10.1016/j.actbio.2012.02.018 ↗
8. Research on an mg–zn alloy as a degradable biomaterial10.1016/j.actbio.2009.06.028 ↗
9. Development of magnesium-based biodegradable metals with dietary trace element germanium as orthopaedic implant applications10.1016/j.actbio.2017.10.004 ↗
10. Effect of sm on the microstructure, mechanical properties and creep behavior of Mg–0.5Zn–0.4 Zr based alloys10.1016/j.msea.2009.10.067 ↗
11. Influence of cerium additions on the corrosion behaviour of high pressure die cast AM50 alloy10.1016/j.corsci.2012.08.011 ↗
12. Understanding magnesium corrosion—a framework for improved alloy performance10.1002/adem.200310405 ↗
13. Effect of rare earth element ce and la on corrosion behavior of AM60 magnesium alloy10.1016/j.corsci.2009.03.018 ↗
14. Influence of ageing treatment on microstructure, mechanical and bio-corrosion properties of Mg–Dy alloys10.1016/j.jmbbm.2012.04.007 ↗
15. Magnesium alloys as implant materials–Principles of property design for Mg–RE alloys10.1016/j.actbio.2009.09.010 ↗
16. Effect of the addition of low rare earth elements (lanthanum, neodymium, cerium) on the biodegradation and biocompatibility of magnesium10.1016/j.actbio.2014.09.041 ↗
17. In vitro and in vivo studies of Mg-30Sc alloys with different phase structure for potential usage within bone10.1016/j.actbio.2019.03.009 ↗
18. A contribution to the rare earth intermetallic chemistry: praseodymium-magnesium alloy system10.1016/0966-9795(93)90010-S ↗
19. ASTM E112-13, Standard Test Methods for Determining Average Grain Size, annual book of ASTM standards, American Society for Testing and Materials, West Conshohocken, PA, 2013.
20. ASTM E8-04, Standard Test Methods for Tension Testing of Metallic Materials, annual book of ASTM standards, American Society for Testing and Materials, West Conshohocken, PA, 2004.
21. ASTM G102-89, Standard Practice for Calculation of Corrosion Rates and Related Information from Electrochemical Measurements, annual book of ASTM standards, American Society for Testing and Materials, West Conshohocken, PA, 2010.
22. ASTM G31-72, Standard Practice for Laboratory Immersion Corrosion Testing of Metals, annual book of ASTM standards, American Society for Testing and Materials, West Conshohocken, PA, 2004.
23. ASTM G1-90, Standard Practice for Preparing, Cleaning, and Evaluating Corrosion Test Specimens, annual book of ASTM standards, American Society for Testing and Materials, West Conshohocken, PA, 1999.
24. Measurement of the corrosion rate of magnesium alloys using tafel extrapolation10.1016/j.corsci.2009.10.016 ↗
25. Interpretation of open circuit potential of two titanium alloys for a long time immersion in physiological fluid
26. Corrosion of magnesium alloy AZ31: the influence of bicarbonate, sulphate, hydrogen phosphate and dihydrogen phosphate ions in saline solution10.1016/j.corsci.2014.05.006 ↗
27. Fundamental theory of biodegradable metals—definition, criteria, and design
28. The influence of pH on the corrosion rate of high-purity mg, AZ91 and ZE41 in bicarbonate buffered hanks' solution10.1016/j.corsci.2015.09.018 ↗
29. Influence of aggressive ions on the degradation behavior of biomedical magnesium alloy in physiological environment10.1016/j.actbio.2008.05.014 ↗
30. Osmotic properties of the erythrocyte: II. the influence of pH, temperature, and oxygen tension on hemolysis by hypotonic solutions10.2307/1537022 ↗
31. Platelet concentration and its effect on bone formation in calvarial defects: an experimental study in rabbits10.1067/mpr.2001.115874 ↗
32. Surface properties and platelet adhesion characteristics of acrylic acid and allylamine plasma‐treated polyethylene10.1002/app.1993.070470908 ↗
33. Precipitation hardening on mechanical and corrosion properties of extruded Mg10Gd modified with ND and LA10.3390/met8080640 ↗
34. Reviews on the influences of alloying elements on the microstructure and mechanical properties of Mg–Li base alloys
35. Microstructure and mechanical properties of extruded Mg–6Zn–Xer alloys10.1016/S1003-6326(13)62808-3 ↗
36. Microstructure and electronic characteristics of the 6H-type abacab Lpso structure in Mg97Zn1Y2 alloy10.1016/j.jallcom.2009.06.045 ↗
37. Effect of multimodal microstructure evolution on mechanical properties of Mg–Zn–Y extruded alloy10.1016/j.actamat.2011.02.038 ↗
38. First-principles study of long-period stacking ordered-like multi-stacking fault structures in pure magnesium10.1016/j.scriptamat.2011.01.039 ↗
39. Influence of biocorrosion on microstructure and mechanical properties of deformed mg–y–er–zn biomaterial containing 18R-LPSO phase10.1016/j.jmbbm.2013.08.012 ↗
40. Effects of grain size on the corrosion resistance of wrought magnesium alloys containing neodymium10.1016/j.corsci.2012.01.021 ↗
41. Corrosion of pure Mg as a function of grain size and processing route10.1002/adem.200800046 ↗
42. Surface grain size effects on the corrosion of magnesium
43. Grain character influences on corrosion of ECAPed pure magnesium10.1179/147842209X12559428167805 ↗
44. Rare earth metals used in biodegradable magnesium‐based stents do not interfere with proliferation of smooth muscle cells but do induce the upregulation of inflammatory genes10.1002/jbm.a.32235 ↗
45. Evaluation of short-term effects of rare earth and other elements used in magnesium alloys on primary cells and cell lines10.1016/j.actbio.2009.09.024 ↗
46. Gadolinium accumulation in organs of sprague–dawleyⓇ rats after implantation of a biodegradable magnesium-gadolinium alloy10.1016/j.actbio.2016.11.024 ↗
47. In vitro and in vivo comparison of binary Mg alloys and pure Mg10.1016/j.msec.2015.12.064 ↗
48. The in vivo and in vitro corrosion of high-purity magnesium and magnesium alloys WZ21 and AZ9110.1016/j.corsci.2013.06.019 ↗
49. Biodegradable magnesium-based screw clinically equivalent to titanium screw in hallux valgus surgery: short term results of the first prospective, randomized, controlled clinical pilot study10.1186/1475-925X-12-62 ↗
50. Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial10.1016/S0140-6736(15)00447-X ↗
51. Motexafin gadolinium: a novel redox active drug for cancer therapy10.1016/j.semcancer.2006.09.002 ↗
52. New samarium (III), gadolinium (III), and dysprosium (III) complexes of coumarin-3-carboxylic acid as antiproliferative agents10.1155/2007/15925 ↗
53. Effects of rare earth compounds on growth and apoptosis of leukemic cell lines10.1290/1071-2690(2002)038<0373:EORECO>2.0.CO;2 ↗
54. Cytotoxicity of biodegradable magnesium alloy WE43 to tumor cells in vitro: bioresorbable implants with antitumor activity?
55. Biocompatibility and degradation of LAE442-based magnesium alloys after implantation of up to 3.5years in a rabbit model10.1016/j.actbio.2016.08.002 ↗
56. In vivo evaluation of a magnesium-based degradable intramedullary nailing system in a sheep model10.1016/j.actbio.2015.07.025 ↗
57. Antibacterial, antifungal and nematicidal activities of rare earth ions10.1007/s12011-016-0727-y ↗
58. Pharmacology and toxicology of the rare earth elements10.1002/jps.2600540502 ↗
59. The skeletal deposition of yttrium, university of california, los angeles campus, school of medicine
60. Metabolism and toxicity of intravenously injected yttrium chloride in rats10.1006/taap.1993.1149 ↗
61. Cerium and yttrium oxide nanoparticles are neuroprotective10.1016/j.bbrc.2006.01.129 ↗
62. Lanthanum carbonate (FosrenolⓇ): a novel agent for the treatment of hyperphosphataemia in renal failure and dialysis patients10.1111/j.1368-5031.2005.00592.x ↗
63. Lanthanum chloride impairs memory, decreases pCaMK IV, pMAPK and pCREB expression of hippocampus in rats10.1016/j.toxlet.2009.07.016 ↗
64. Methemoglobinemia by cerium nitrate poisoning10.1016/j.burns.2006.04.005 ↗
65. Toxicological evaluations of rare earths and their health impacts to workers: a literature review10.5491/SHAW.2013.4.1.12 ↗
66. Toxicological and cytophysiological aspects of lanthanides action10.18388/abp.2000_3963 ↗
67. The degradation and transport mechanism of a Mg-Nd-Zn-Zr stent in rabbit common carotid artery: a 20-month study10.1016/j.actbio.2018.01.018 ↗
68. The use of neodymium magnets in healthcare and their effects on health
69. Cytotoxicity of the rare earth metals cerium, lanthanum, and neodymium in vitro: comparisons with cadmium in a pulmonary macrophage primary culture system10.1016/S0013-9351(87)80066-X ↗
70. Effects of samarium on liver and kidney of rats10.1016/S1002-0721(07)60416-5 ↗
71. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases10.1200/JCO.2002.20.1.189 ↗
72. Distribution of samarium and ytterbium in rats measured by enriched stable isotope tracer technique and Inaa10.1023/A:1014886226165 ↗
73. In vivo toxicity studies of europium hydroxide nanorods in mice10.1016/j.taap.2009.07.009 ↗
74. Toxicity study of europium chloride in rats
75. Pharmacology and toxicology of europium chloride10.1002/jps.2600540435 ↗
76. The elements of life and medicines
77. A europium (III)-based paracest agent for sensing singlet oxygen by MRI10.1039/c3dt50194a ↗
78. Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure10.1016/j.berh.2012.07.008 ↗
79. Determination of terbium in organs of mice administered terbium chloride: comparative study of fluorometry and atomic absorption spectrometry10.1093/jat/13.3.135 ↗
80. Pharmacology and toxicology of terbium, thulium, and ytterbium chlorides10.1016/0041-008X(63)90014-0 ↗
81. Clinical evaluation of the radiolanthanide terbium-152: first-in-human pet/ct with 152Tb-DOTATOC10.1039/C7DT01936J ↗
82. Possible radiation therapy of cephalic neoplasms by perfusion of short-lived isotopes. II. dysprosium-165: metabolism in mouse and cat
83. Toxicity of dysprosium shift reagents in the isolated perfused rat kidney10.1002/mrm.1910110215 ↗
84. The use of gadolinium and dysprosium chelate complexes as contrast agents for magnetic resonance imaging10.1016/0925-8388(94)90168-6 ↗
85. Distribution of the transuranic elements in mammals10.1097/00004032-196212000-00015 ↗
86. Pharmacology and toxicology of dysprosium, holmium, and erbium chlorides10.1016/0041-008X(66)90098-6 ↗
87. Clinical use of the holmium: yag laser in laparoscopic partial nephrectomy10.1089/089277902760102767 ↗
88. Erbium:YAG versus holmium:yag lithotripsy10.1016/S0022-5347(05)66548-2 ↗
89. Soft and hard tissue ablation with short-pulse high peak power and continuous thulium-silica fibre lasers10.1007/s10103-003-0267-5 ↗
90. Zero ischemia laparoscopic partial thulium laser nephrectomy10.1089/end.2012.0527 ↗
91. Taylor · 2016
92. Pharmacology and toxicology of lutetium chloride10.1002/jps.2600531011 ↗
93. Biomedical applications of lanthanide (III) texaphyrins lutetium (III) texaphyrins as potential photodynamic therapy photosensitizers10.1016/S0925-8388(96)02517-0 ↗
94. 177Lu-labeled antibodies for EGFR-targeted spect/ct imaging and radioimmunotherapy in a preclinical head and neck carcinoma model10.1021/mp4005047 ↗
95. Emsley · 2011
96. In vitro and in vivo studies on biomedical magnesium low-alloying with elements gadolinium and zinc for orthopedic implant applications10.1021/acsami.7b15498 ↗
97. Comparative, real-time in situ monitoring of galvanic corrosion in mg-mg2ca and mg-mgzn2 couples in hank's solution10.1016/j.corsci.2019.108185 ↗